The researchers compared three ways of grouping people with MASLD: metabolic clusters, liver and cardiometabolic traits, and biochemical injury patterns. They assessed changes using MRI-based liver-fat measurements, ALT levels and liver-stiffness measurements rather than repeated liver biopsies.

Metabolic clusters were more stable over time than the other two classification systems. Several subgroups also had different response patterns, including lower liver-fat response in the high-lipoprotein(a) group, lower ALT response in the age-related group and a stronger liver-stiffness response in the mild-obesity/dyslipidemia group. These findings describe associations within this cohort and do not establish that a particular classification or treatment approach improves outcomes.